Delivery Order SPE2DB22D3501-SPE2DB25FVW20

Award Date 5/29/25
Potential Completion Date 5/30/25
Potential Value $1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Colestipol HCL 1 GM Tablets. The contract has a ceiling value of $4,411.65 and a period of performance through May 9, 2025. It is a firm-fixed-price contract, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Colestipol HCL 1 GM Tablets, with a ceiling value of $1,157.80 and a performance period ending on May 20, 2025. The contract is a Firm Fixed Price type and is not set aside for any specific business category. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,106.98, is for the delivery of Colestipol HCL 1 GM Tablets in quantities of 120s. The contract has an ultimate completion date of March 18, 2025 and is a firm fixed-price contract. This order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor, for the supply of Colestipol HCL 1 GM Tablets. The contract has a firm fixed price of $1,151.46 and an ultimate completion date of September 16, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which enables the agency to...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Colestipol Hydrochloride 1 gram tablets, a medication used to treat high cholesterol. The contract has a ceiling value of $2,250.86 and is a firm fixed-price contract with an ultimate completion date of April 22, 2025. The contract is not designated as a set-aside and was awarded on April...
This federal contract award, valued at $1,753.71, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order and is for the supply of Colestipol HCL 1 GM Tablets in quantities of 120 tablets. The award is part of a larger Indefinite Delivery Contract (IDC) worth $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical. This IDC serves as a primary...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price valued at $1,321.02 and runs through January 29, 2025. It is not designated as a set-aside contract. The award is for the delivery of COLESTIPOL HCL 1 GM TABLET 120S, a pharmaceutical product, to support military and federal healthcare programs. AmerisourceBergen...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to the Corporate Office division of Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,348.33 firm fixed price contract is for the delivery of 4,564,286,736 colestipol hydrochloride 1 gram tablets. This award is associated with Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00, to provide a wide range of...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division for the provision of 4,564,840,868 units of Colestipol Hydrochloride 1 gram tablets. The delivery order has a ceiling value of $5,068.32 and is a firm fixed-price contract. Amerisourcebergen Drug Corp is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, particularly the Department of Defense (DoD) and Veterans Affairs...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,065.94 Firm Fixed Price Delivery Order is for the supply of 120 tablets of Colestipol HCL 1 GM, a medication used to treat high cholesterol. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical to provide a comprehensive...
  • SPE2DB22D3501
    Indefinite Delivery Contract
  • SPE2DB22D3501-SPE2DB25FVW20
    Delivery Order

This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Colestipol HCL 1 GM Tablets, with a ceiling value of $1,029.69 and a period of performance through May 30, 2025.

Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This delivery order contract is not set-aside and allows the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard.

Generated 8/28/25, 10:01 AM